Icon

RAPIVAB (nda206426)- (200MG/20ML (10MG/ML))

PERAMIVIR BIOCRYST
200MG/20ML (10MG/ML)
No No
2027-May-07 2019-Dec-19
None None
None No
RAPIVAB is an influenza virus neuraminidase inhibitor indicated for the treatment of acute uncomplicated influenza in patients 6 months and older who have been symptomatic for no more than two days.
0 0 0
Total Other Developers None
Drugs with Suitability No
200MG/20ML (10MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.